Related Experiment Video
Updated: Jun 30, 2026
![Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F62334.jpg&w=3840&q=50)
09:34
Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography
Published on: February 17, 2022
Multi-dimensional orchestration of binders for improved CAR-T immunotherapy
Chaoyang Zhu1, Zhiwu Jiang1, Rui Jing1
1Houston Methodist Neal Cancer Center, Weill Cornell Medicine, Houston, TX, 77030, USA.
Cancer Letters
|June 28, 2026
Summary
Optimizing chimeric antigen receptor (CAR)-T cell therapy requires a multidimensional binder design strategy, integrating multiple parameters beyond affinity for enhanced efficacy and safety in cancer treatment.
Area of Science:
- Immunology
- Biotechnology
- Cancer Therapy
Background:
- Antigen-binding domains (binders) are critical components in chimeric antigen receptor (CAR)-T cell engineering.
- Binder properties significantly influence CAR-T cell selectivity, signaling, persistence, and toxicity.
Purpose of the Study:
- To review advances in binder design for CAR-T cell therapy.
- To propose a multidimensional design strategy for optimal CAR performance.
- To highlight the impact of binder design on clinical translation.
Main Methods:
- Synthesis of recent research on binder design parameters.
- Analysis of how epitope position, kinetics, avidity, geometry, and stability impact CAR-T cell function.
- Examination of the expanding landscape of binder formats.
Main Results:
- Optimal CAR performance necessitates integrating multiple binder design parameters, not just affinity.
- These parameters collectively regulate immunological synapse formation, antigen discrimination, and functional durability.
- Binder design choices have significant clinical implications.
Conclusions:
- A shift from empirical selection to rational orchestration of binders is crucial for next-generation CAR-T therapies.
- Multidimensional binder design is foundational for improving CAR-T cell immunotherapy.
- Integrating diverse binder formats, including novel engineered proteins, expands therapeutic potential.
